Service de Maladies Infectieuses, Hôpital de La Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Université Claude Bernard Lyon 1, Lyon, France.
Genome Med. 2020 Jun 30;12(1):58. doi: 10.1186/s13073-020-00757-y.
Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of precision medicine in gastrointestinal disorders.
粪便微生物群移植(FMT)在越来越多的随机对照试验中已被证明可有效治疗炎症性肠病和肠易激综合征。最近发表的数据为与 FMT 成功相关的因素提供了引人注目的见解,为胃肠道疾病的精准医学应用铺平了道路。